Also known as: prabotulinumtoxin a, prabotulinumtoxin-a, prabotulinumtoxin a-xvfs, prabotulinumtoxin-a xvfs, evolus neurotoxin, newtox, jeuveau tox, jeuveau botulinum toxin, jeuveau botox, jeuveau injectable
Jeuveau (prabotulinumtoxinA) is a prescription injectable neuromodulator that represents the newest advancement in botulinum toxin type A treatments for facial aesthetics. Approved by the FDA in 2019, Jeuveau was the first new neurotoxin for cosmetic use to receive FDA approval in over a decade, ear...